Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS    BLOG    You Tube

Journal of Pharmacogenomics & Pharmacoproteomics

Open Access
ISSN: 2153-0645
In Association with

Upcoming Event


About the Journal

Editors Recommendation for Indexing
Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic variations on drug response in patients. Pharmacoproteomics is the use of proteomic technologies in drug discovery and development. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.
The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.
Journal of Pharmacogenomics & Pharmacoproteomics is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
flyer image Impact Factor: 1.3 *
Index Copernicus Value: 4.76

OMICS group open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality and reliable manuscripts for the readers and authors of scholarly, academic and scientific field. 

The journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Pharmacogenomics & Pharmacoproteomics or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Submit manuscript at www.editorialmanager.com/omicsgroup/ or send as an e-mail attachment to the Editorial Office at editor.jpp@omicsonline.org


Recently published articles

How to Personalize Pharmacoproteomics?
Victor P Andreev
Beyond IC50s: Towards Robust Statistical Methods for in vitro Association Studies
Andrew Beam and Alison Motsinger-Reif
Genomic Loci Evaluation with Albuminuria in New-Onset Insulin Dependent Diabetic Patients
Anna Sleder, Jia Li, Andrea Cassidy-Bushrow, Sharon Cresci, Keoki Williams, Hani N Sabbah and David Lanfear
Early Outline Evaluation of Genotyping Costs of Pharmacogenomics
Angela De Monaco, Massimiliano Berretta, Sergio Pugliese, Daniela Valente and Raffaele Di Francia
Factor 8 Gene Mutations and Risk of Inhibitor Development in Hemophilia A Algerian Patients
Faouzia Zemani-Fodil, Meriem Abdi, Mostefa Fodil, Meriem Samia Aberkane, Naima Mesli, Mohamed Belazaar, Malika Mehalhal, Yasmina Rahal, Hadj Touhami, Nadhira Saidi-Mehtar and Abdallah Boudjema
A Proposal for an Individualized Pharmacogenetic-Guided Warfarin Dosage Regimen for Puerto Rican Patients Commencing Anticoagulation Therapy
Luis Ángel Bermúdez Bosch
© 2008–2014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version